Priapism Treatment Market Size, Share & Growth Report | 2032

Report Description

Market Outlook:

The global priapism treatment market was valued at USD 328.8 Million in 2023 and is anticipated to reach USD 599.4 Million by 2032, expanding at a CAGR of 6.9% during the forecast period.
 
Priapism is a prolonged and painful erection of the penis lasting more than four hours without sexual stimulation. Priapism is divided into two types: ischemic priapism and nonischemic priapism. In ischemic priapism, blood is unable to flow out of the penis, requiring immediate treatment. Aspiration decompression (draining blood) procedure and medications such as phenylephrine are used in this case. In nonischemic priapism, erection persists without rigidity.

Get Free Sample Report

COVID-19 Impact on the Global Priapism Treatment Market

The COVID-19 pandemic had a significant impact on the market. The demand for priapism treatment decreased during the initial phase of the pandemic. Some studies suggest that COVID-19 survivors can experience short and long-term sexual and reproductive health issues, including erectile dysfunction. The virus affects blood vessels, potentially disrupting blood flow necessary for erections.

Artificial Intelligence (AI) Impact on the Global Priapism Treatment Market

Artificial intelligence (AI) has the potential to enhance priapism treatment.

Diagnosis: AI algorithms aid in rapid diagnosis based on clinical data and imaging.
Treatment Optimization: AI predicts optimal interventions based on patient-specific factors.
Outcome Prediction: AI models predict outcomes and guide personalized management.

Macro-economic Factors

Cost of Treatment

The cost of treatment is one of the significant factors that determine the affordability of a cure. Advancements in medical technology have made it possible to cure diseases that were once considered incurable. However, it is impossible for a middle-income level person to afford advanced treatments, due to their high cost. Thus, the cost of treatment is a major factor impacting the market.

Awareness & Knowledge

Lack of awareness about diseases and knowledge of screening and treatment options create barriers to the economic growth of a country in an indirect manner. Health promotion is the process of empowering people to upsurge control over their health, and its determinants through health literacy efforts and various course of action increase healthy behaviors. The US and Europe have more knowledge and awareness of diseases compared to other regions, such as Asia Pacific and the Middle East. Many countries run campaigns to spread information as preventative measures within the community or a group of people.

Market Dynamics

Major Driver: Technological Advancements in Treatment Modalities

The development of innovative treatment modalities, including pharmacological agents, penile aspiration techniques, and surgical procedures, enhances the efficacy and safety of priapism treatment. Advancements such as targeted drug delivery systems, minimally invasive surgical techniques, and improved imaging modalities enable healthcare providers to tailor treatment approaches to individual patient needs.

Priapism is managed by controlling the acute pain, resolving the acute event, preserving erectile function, and preventing the risk of future recurrences. Various methods are used for the management of priapism. These methods include cavernosal decompression, surgical shunts, and the implantation of penile prosthesis in the acute care setting.

Technological advancements in priapism treatment modalities drive innovation, expand therapeutic options, and improve the quality of care for patients affected by this challenging condition. This, in turn, drives the market during the forecast period.   

Existing Restraint: Stringent Regulatory Guidelines

The market expansion is significantly impeded by the high cost of healthcare simulation. Additional expenses and effort are associated with the necessity for qualified operators for gears and software. Consequently, simulation costs are rising, and product uptake is being constrained. Virtual reality (VR), augmented reality (AR), and artificial intelligence (AI) technologies, however, are anticipated to help resolve this problem.

For instance, in May 2022, the American Urological Association (AUA) partnered with the Sexual Medicine Society of North America (SMSNA) and released the 2022 clinical guideline for the diagnosis and management of priapism. The guideline provides a clinical framework for the treatment (non-surgical and surgical) of nonischemic priapism, recurrent ischemic priapism, and priapism.  

Emerging Opportunity: Increasing Awareness about Priapism

Increased awareness ensures that individuals experiencing priapism recognize the symptoms early and seek prompt medical attention. Early intervention helps prevent complications and improve outcomes. Awareness of priapism can be raised through various channels, including public health campaigns, educational materials in healthcare settings, online resources, and community outreach programs. Additionally, healthcare professionals play a crucial role in educating their patients about priapism during routine clinical encounters and addressing any concerns or questions they may have.

Sickle cell disorder is an inherited blood condition and a genetic disease that affects people across the globe. Sickle cell disorders predispose people to pain, anemia, infections, and priapism.

For instance, according to an article published by Boston Scientific Corporation in June 2023, there were about 15,000 people with sickle cell disease in the UK, and this continues to grow with around 250 births each year. Priapism is a common issue for young men with sickle cell and can affect up to 50%. Thus, it is important to raise awareness of the serious effects if priapism is left untreated.

Scope of the Report   

The report on the global priapism treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Segmental Outlook

On the basis of priapism type, the global priapism treatment market is bifurcated into ischemic priapism and nonischemic priapism. The ischemic priapism segment held a 74.21% share of the market in 2023 and is projected to expand at a significant CAGR in the coming years. Conditions such as sickle cell disease, certain medications, and illicit drug use contribute to the rising incidence of ischemic priapism, thereby boosting the segment.

Get Free Sample Report

Based on treatment, the global priapism treatment market is divided into medications, surgery, psychological counselling, penis pumps, penile implants, and others. The medications segment held a 65.40% market share in 2023. Innovations in medications, such as phenylephrine injections, help manage priapism and increased awareness leads to early diagnosis and treatment, driving demand for medications.

Get Free Sample Report

Based on route of administration, the global priapism treatment market is segmented into oral, intravenous, and others. The Intravenous segment held a 45.12% market share in 2023. Increased prescription of affordable generic products such as sildenafil enhances patient compliance and expands the consumer base, contributing to segmental growth.

Get Free Sample Report

Regional Outlook

On the basis of region, the global priapism treatment market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (MEA).

North America held a 45.23% share of the market in 2023, owing to the rapid development of healthcare infrastructure in recent years to provide valuable healthcare services to patients. The market in Asia Pacific is anticipated to expand at a CAGR of 12.8% during the forecast period, due to the well-established healthcare system in the region. Additionally, the rising demand for effective medications to manage priapism and the rise in research & development efforts aimed at creating innovative drug molecules propel the market in the region.

The market in Europe is expected to expand at a significant growth rate in the coming years, due to the rising awareness about the disease & increasing development of generic drugs. The market in Latin America is projected to register a considerable CAGR during the forecast period, owing to the increasing demand for quality healthcare services.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Priapism Treatment Market
• Historical, Current, and Projected Market Size in terms of Value
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints, and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on Global Priapism Treatment Market performance